These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36209227)

  • 41. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    ; Austin T; Boyd J
    Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
    Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
    BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supporting the full participation of people who use drugs in policy fora: Provision of a temporary, conference-based overdose prevention site.
    Brooks HL; Husband C; Taylor M; Sherren A; Hyshka E
    Int J Drug Policy; 2020 Oct; 84():102878. PubMed ID: 32739614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "There are solutions and I think we're still working in the problem": The limitations of decriminalization under the good Samaritan drug overdose act and lessons from an evaluation in British Columbia, Canada.
    Xavier J; Greer A; Pauly B; Loyal J; Mamdani Z; Ackermann E; Barbic S; Buxton JA
    Int J Drug Policy; 2022 Jul; 105():103714. PubMed ID: 35561485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.
    Selfridge M; Card K; Kandler T; Flanagan E; Lerhe E; Heaslip A; Nguyen A; Moher M; Pauly B; Urbanoski K; Fraser C
    Int J Drug Policy; 2022 Jul; 105():103709. PubMed ID: 35525052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study.
    Lew B; Bodkin C; Lennox R; O'Shea T; Wiwcharuk G; Turner S
    Harm Reduct J; 2022 Mar; 19(1):29. PubMed ID: 35313903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada.
    Tzemis D; Campbell J; Kuo M; Buxton JA
    Subst Abuse Treat Prev Policy; 2013 Dec; 8():40. PubMed ID: 24289280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and outcomes of paid undergraduate student nurse positions.
    Gamroth L; Budgen C; Lougheed M
    Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders.
    Chau LW; Erickson M; Vigo D; Lou H; Pakhomova T; Winston ML; MacPherson D; Thomson E; Small W
    Int J Drug Policy; 2021 Nov; 97():103208. PubMed ID: 34058669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "It's like super structural" - Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia.
    Selfridge M; Greer A; Card KG; Macdonald S; Pauly B
    Int J Drug Policy; 2020 Feb; 76():102623. PubMed ID: 31865117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19.
    McCrae K; Glegg S; Goyer MÉ; Le Foll B; Brar R; Sutherland C; Fairbairn N
    Harm Reduct J; 2022 Jul; 19(1):77. PubMed ID: 35836189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study.
    Ackermann E; Kievit B; Xavier J; Barbic S; Ferguson M; Greer A; Loyal J; Mamdani Z; Palis H; Pauly B; Slaunwhite A; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):42. PubMed ID: 35614474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical studies of harm reduction: Overdose response in uncertain political times.
    Watson TM; Kolla G; van der Meulen E; Dodd Z
    Int J Drug Policy; 2020 Feb; 76():102615. PubMed ID: 31837567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
    Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
    Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The drug war must end: The right to life, liberty and security of the person during the COVID-19 pandemic for people who use drugs.
    ; ; ; Maynard R; Jozaghi E
    Harm Reduct J; 2021 Feb; 18(1):21. PubMed ID: 33596901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.